New combination therapy for pancreatic carcinomas and colon cancer

The current invention is based on combination therapies of nucleoside analogs with inhibitors of either the Nodal/Activin pathway or the mTOR / hedgehog pathway and show a remarkable capacity to eliminate cancer stem cells

and to subsequently inhibit pancreatic and/or colon cancer.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

Alle Nachrichten aus der Kategorie: Technology Offerings

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

Fermented wool is the answer

FAU researchers reveal the secret of the famous Pazyryk carpet Why are the red, yellow, and blue colours used in the world’s oldest knotted-pile carpet still so vivid and bright,…

Advance in ‘optical tweezers’ to boost biomedical research

Much like the Jedis in Star Wars use ‘the force’ to control objects from a distance, scientists can use light or ‘optical force’ to move very small particles. The inventors…

New form of symbiosis discovered

They are also called power plants of the cells: the mitochondria. They are present in almost all eukaryotic cells and they supply the cells with energy. Until now, it was…

Partners & Sponsors